Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays.

Yamamoto G, Nannya Y, Kato M, Sanada M, Levine RL, Kawamata N, Hangaishi A, Kurokawa M, Chiba S, Gilliland DG, Koeffler HP, Ogawa S.

Am J Hum Genet. 2007 Jul;81(1):114-26. Epub 2007 Jun 5.

2.

Single-nucleotide polymorphism array karyotyping in clinical practice: where, when, and how?

Sato-Otsubo A, Sanada M, Ogawa S.

Semin Oncol. 2012 Feb;39(1):13-25. doi: 10.1053/j.seminoncol.2011.11.010. Review.

PMID:
22289488
4.

Single nucleotide polymorphism array analysis of cancer.

Dutt A, Beroukhim R.

Curr Opin Oncol. 2007 Jan;19(1):43-9. Review.

PMID:
17133111
5.

[Advances in high-density whole genome-wide single nucleotide polymorphism array in cancer research].

Zeng ZY, Xiong W, Zhou YH, Li XL, Li GY.

Ai Zheng. 2006 Nov;25(11):1454-8. Review. Chinese.

PMID:
17094921
6.

The consequences of uniparental disomy and copy number neutral loss-of-heterozygosity during human development and cancer.

Lapunzina P, Monk D.

Biol Cell. 2011 Jul;103(7):303-17. doi: 10.1042/BC20110013. Review.

PMID:
21651501
7.

Mapping genetic alterations in tumors with single nucleotide polymorphisms.

Zhou W.

Curr Opin Oncol. 2003 Jan;15(1):50-4. Review.

PMID:
12490761
8.

Diagnostic implications of excessive homozygosity detected by SNP-based microarrays: consanguinity, uniparental disomy, and recessive single-gene mutations.

Kearney HM, Kearney JB, Conlin LK.

Clin Lab Med. 2011 Dec;31(4):595-613, ix. doi: 10.1016/j.cll.2011.08.003. Epub 2011 Oct 20. Review.

PMID:
22118739
9.
10.

Acquired uniparental disomy in myeloproliferative neoplasms.

Score J, Cross NC.

Hematol Oncol Clin North Am. 2012 Oct;26(5):981-91. doi: 10.1016/j.hoc.2012.07.002. Epub 2012 Aug 18. Review.

PMID:
23009933
11.

Mutant allele specific imbalance in oncogenes with copy number alterations: Occurrence, mechanisms, and potential clinical implications.

Yu CC, Qiu W, Juang CS, Mansukhani MM, Halmos B, Su GH.

Cancer Lett. 2017 Jan 1;384:86-93. doi: 10.1016/j.canlet.2016.10.013. Epub 2016 Oct 8. Review.

PMID:
27725226
12.

Pathogenesis and consequences of uniparental disomy in cancer.

Makishima H, Maciejewski JP.

Clin Cancer Res. 2011 Jun 15;17(12):3913-23. doi: 10.1158/1078-0432.CCR-10-2900. Epub 2011 Apr 25. Review.

13.

Genome-wide SNP analysis in cancer: leukemia shows the way.

Wang Y, Armstrong SA.

Cancer Cell. 2007 Apr;11(4):308-9. Review.

14.

SNP array analysis in hematologic malignancies: avoiding false discoveries.

Heinrichs S, Li C, Look AT.

Blood. 2010 May 27;115(21):4157-61. doi: 10.1182/blood-2009-11-203182. Epub 2010 Mar 19. Review.

15.

Molecular inversion probes: a novel microarray technology and its application in cancer research.

Wang Y, Cottman M, Schiffman JD.

Cancer Genet. 2012 Jul-Aug;205(7-8):341-55. doi: 10.1016/j.cancergen.2012.06.005. Review.

PMID:
22867995
16.

Using DNA microarrays to study natural variation.

Gilad Y, Borevitz J.

Curr Opin Genet Dev. 2006 Dec;16(6):553-8. Epub 2006 Sep 27. Review.

PMID:
17008090
17.

Technology Insight: querying the genome with microarrays--progress and hope for neurological disease.

Coppola G, Geschwind DH.

Nat Clin Pract Neurol. 2006 Mar;2(3):147-58. Review.

PMID:
16932541
18.

Clinical utility of single nucleotide polymorphism arrays.

Schwartz S.

Clin Lab Med. 2011 Dec;31(4):581-94, viii. doi: 10.1016/j.cll.2011.09.002. Review.

PMID:
22118738
19.

Methods for detection of subtle mutations in cancer genomes.

Dahl C, Ralfkiaer U, Guldberg P.

Crit Rev Oncog. 2006 Jul;12(1-2):41-74. Review.

PMID:
17078206
20.

Emerging paradigms in cancer genetics: some important findings from high-density single nucleotide polymorphism array studies.

Bacolod MD, Schemmann GS, Giardina SF, Paty P, Notterman DA, Barany F.

Cancer Res. 2009 Feb 1;69(3):723-7. doi: 10.1158/0008-5472.CAN-08-3543. Epub 2009 Jan 20. Review.

Supplemental Content

Support Center